Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
clinical trial
Press Enter · cited answer in seconds
0 sources
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
Summary
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis is a clinical trial[1].
Key Facts
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis is in the country of United States[2].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's instance of is recorded as clinical trial[3].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's start time is recorded as +2018-03-15T00:00:00Z[4].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's end time is recorded as +2021-01-01T00:00:00Z[5].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's main subject is recorded as colitis[6].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's number of participants is recorded as {'unit': '1', 'amount': '+150'}[7].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's title is recorded as A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis[8].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's short name is recorded as CALDOSE-1[9].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's ClinicalTrials.gov ID is recorded as NCT03341962[11].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}[12].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research intervention is recorded as calcium oxalate[13].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's clinical trial phase is recorded as phase II clinical trial[14].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research site is recorded as AXIS Clinical Trials[15].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research site is recorded as Albert Schweitzer Hospital[16].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research site is recorded as Kazan State Medical University[17].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research site is recorded as Russian Academy of Medical Sciences[18].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research site is recorded as Clinical Centre of Kragujevac[19].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research site is recorded as Clinical Centre of Niš[20].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's research site is recorded as University of London[21].
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis's study type is recorded as interventional study[22].